SCHEMBL25818697

SCHEMBL25818697

CO[C@H]1C(OC(C)(C)C)[C@@H](COC(C)(C)C)O[C@H]1n1cnc2c(N)ncnc21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 6/20 0.54
ADORA3 P0DMS8 5/20 0.50
SMN1; SMN2 Q16637 2/20 0.48
ADORA2A P29274 2/20 0.48
ADORA2B P29275 2/20 0.48
DPP4 P27487 1/20 0.48
MEN1 O00255 1/20 0.48
SLC28A1 O00337 1/20 0.48
MAP3K7 O43318 1/20 0.48
SLC28A2 O43868 1/20 0.48
GAPDH P04406 1/20 0.48
MAPK1 P28482 1/20 0.48
STAT6 P42226 1/20 0.48
PI4KA P42356 1/20 0.48
KMT2A Q03164 1/20 0.48
PI4K2B Q8TCG2 1/20 0.48
DOT1L Q8TEK3 1/20 0.48
SLC29A1 Q99808 1/20 0.48
PI4K2A Q9BTU6 1/20 0.48
SLC28A3 Q9HAS3 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25819528 1.00 ADORA1 (0.54) ADORA1ADORA3SMN1; SMN2ADORA2AADORA2B
SCHEMBL23644632 0.95 ADORA1 (0.56) ADORA1ADORA3SMN1; SMN2ADORA2AADORA2B
SCHEMBL19887015 0.89 ADORA3 (0.51) ADORA1ADORA3SMN1; SMN2ADORA2AADORA2B
SCHEMBL19522864 0.89 ADORA3 (0.51) ADORA1ADORA3SMN1; SMN2ADORA2AADORA2B
SCHEMBL15280867 0.89 ADORA3 (0.51) ADORA1ADORA3SMN1; SMN2ADORA2AADORA2B
SCHEMBL18510799 0.88 ADORA1 (0.64) ADORA1ADORA3SMN1; SMN2ADORA2AADORA2B
SCHEMBL24239298 0.88 ADORA1 (0.64) ADORA1ADORA3SMN1; SMN2ADORA2AADORA2B
SCHEMBL22399462 0.88 ADORA1 (0.64) ADORA1ADORA3SMN1; SMN2ADORA2AADORA2B
SCHEMBL18510800 0.88 ADORA1 (0.64) ADORA1ADORA3SMN1; SMN2ADORA2AADORA2B
SCHEMBL24239296 0.88 ADORA1 (0.64) ADORA1ADORA3SMN1; SMN2ADORA2AADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230212572-A1 Guanosine Analogues for Use in Therapeutics Polynucleotides ROCHE INNOVATION CENTER COPENHAGEN A/S (DK) 2023-07-06 US disclosed